{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:34:19Z","timestamp":1791844459325,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-024-05885-w","type":"journal-article","created":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T07:16:04Z","timestamp":1731741364000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Cardiac safety of antipsychotic medications in pediatric and adolescent population: a systematic review and pathways for future research"],"prefix":"10.1007","volume":"184","author":[{"given":"Simone","family":"Gasparini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Senese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Scuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Parodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Gianfredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ciabattini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Loddo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Peroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Porcedda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Pisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,16]]},"reference":[{"key":"5885_CR1","doi-asserted-by":"crossref","unstructured":"Pillay J, Boylan K, Carrey N, Newton A, Vandermeer B, Nuspl M, MacGregor T, Jafri SHA, Featherstone R, Hartling L (2017) First- and second-generation antipsychotics in children and young adults: systematic review update. Agency for Healthcare Research and Quality (US)","DOI":"10.1177\/0706743718779950"},{"key":"5885_CR2","doi-asserted-by":"publisher","first-page":"e117","DOI":"10.1017\/S2045796020000293","volume":"29","author":"F Kaguelidou","year":"2020","unstructured":"Kaguelidou F, Holstiege J, Schink T, Bezemer I, Poluzzi E, Mazzaglia G, Pedersen L, Sturkenboom M, Trifir\u00f2 G (2020) Use of antipsychotics in children and adolescents: a picture from the ARITMO population-based European cohort study. Epidemiol Psychiatr Sci 29:e117. https:\/\/doi.org\/10.1017\/S2045796020000293","journal-title":"Epidemiol Psychiatr Sci"},{"issue":"11\u201312","key":"5885_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s10354-007-0379-9","volume":"157","author":"A Baranyi","year":"2007","unstructured":"Baranyi A, Yazdani R, Haas-Krammer A, Stepan A, Kapfhammer HP, Rothenh\u00e4usler HB (2007) Atypische Neuroleptika und metabolisches Syndrom [Atypical antipsychotics and metabolic syndrome]. Wien Med Wochenschr 157(11\u201312):255\u2013270. https:\/\/doi.org\/10.1007\/s10354-007-0379-9","journal-title":"Wien Med Wochenschr"},{"issue":"5","key":"5885_CR4","doi-asserted-by":"publisher","first-page":"582","DOI":"10.3390\/children11050582","volume":"11","author":"E Balestra","year":"2024","unstructured":"Balestra E, Bobbo M, Cittar M, Chicco D, D\u2019Agata Mottolese B, Barbi E, Caiffa T (2024) Congenital long QT syndrome in children and adolescents: a general overview. Children (Basel, Switzerland) 11(5):582. https:\/\/doi.org\/10.3390\/children11050582","journal-title":"Children (Basel, Switzerland)"},{"issue":"7","key":"5885_CR5","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1111\/j.1540-8159.2000.tb00912.x","volume":"23","author":"J Kassotis","year":"2000","unstructured":"Kassotis J, Costeas C, Bedi AK, Tolat A, Reiffel J (2000) Effects of aging and gender on QT dispersion in an overtly healthy population. Pacing Clin Electrophysiol\u202f: PACE 23(7):1121\u20131126. https:\/\/doi.org\/10.1111\/j.1540-8159.2000.tb00912.x","journal-title":"Pacing Clin Electrophysiol : PACE"},{"issue":"1","key":"5885_CR6","doi-asserted-by":"publisher","first-page":"e13015","DOI":"10.1111\/anec.13015","volume":"28","author":"DT Tardo","year":"2023","unstructured":"Tardo DT, Peck M, Subbiah RN, Vandenberg JI, Hill AP (2023) The diagnostic role of T wave morphology biomarkers in congenital and acquired long QT syndrome: a systematic review. Ann Noninvasive Electrocardiol\u202f: Off J Int Soc Holter Noninvasive Electrocardiol Inc 28(1):e13015. https:\/\/doi.org\/10.1111\/anec.13015","journal-title":"Ann Noninvasive Electrocardiol : Off J Int Soc Holter Noninvasive Electrocardiol Inc"},{"issue":"5","key":"5885_CR7","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.jacep.2022.02.017","volume":"8","author":"AD Krahn","year":"2022","unstructured":"Krahn AD, Laksman Z, Sy RW, Postema PG, Ackerman MJ, Wilde AAM, Han HC (2022) Congenital long QT syndrome. JACC Clin Electrophysiol 8(5):687\u2013706. https:\/\/doi.org\/10.1016\/j.jacep.2022.02.017","journal-title":"JACC Clin Electrophysiol"},{"issue":"13","key":"5885_CR8","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.jacc.2015.12.063","volume":"67","author":"PJ Schwartz","year":"2016","unstructured":"Schwartz PJ, Woosley RL (2016) Predicting the unpredictable: drug-induced QT prolongation and Torsades de Pointes. J Am Coll Cardiol 67(13):1639\u20131650. https:\/\/doi.org\/10.1016\/j.jacc.2015.12.063","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"5885_CR9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.mayocp.2013.01.013","volume":"88","author":"KH Haugaa","year":"2013","unstructured":"Haugaa KH, Bos JM, Tarrell RF, Morlan BW, Caraballo PJ, Ackerman MJ (2013) Institution-wide QT alert system identifies patients with a high risk of mortality. Mayo Clin Proc 88(4):315\u2013325. https:\/\/doi.org\/10.1016\/j.mayocp.2013.01.013","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"5885_CR10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1161\/CIRCOUTCOMES.113.000152","volume":"6","author":"JE Tisdale","year":"2013","unstructured":"Tisdale JE, Jaynes HA, Kingery JR, Mourad NA, Trujillo TN, Overholser BR, Kovacs RJ (2013) Development and validation of a risk score to predict QT interval prolongation in hospitalized patients. Circ Cardiovasc Qual Outcomes 6(4):479\u2013487. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.113.000152","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"1","key":"5885_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s13643-017-0663-8","volume":"6","author":"MJ Page","year":"2017","unstructured":"Page MJ, Moher D (2017) Evaluations of the uptake and impact of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) Statement and extensions: a scoping review. Syst Rev 6(1):263. https:\/\/doi.org\/10.1186\/s13643-017-0663-8","journal-title":"Syst Rev"},{"issue":"6","key":"5885_CR12","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1136\/emermed-2020-209567","volume":"37","author":"M Amir-Behghadami","year":"2020","unstructured":"Amir-Behghadami M, Janati A (2020) Population, Intervention, Comparison, Outcomes and Study (PICOS) design as a framework to formulate eligibility criteria in systematic reviews. Emergency medicine journal\u202f: EMJ 37(6):387. https:\/\/doi.org\/10.1136\/emermed-2020-209567","journal-title":"Emergency medicine journal : EMJ"},{"key":"5885_CR13","unstructured":"Oxford Centre for Evidence-Based Medicine (2011) OCEBM levels of evidence working group. The Oxford Levels of Evidence 2. Available from: https:\/\/www.cebm.ox.ac.uk\/resources\/levels-of-evidence\/ocebm-levels-of-evidence."},{"key":"5885_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pnpbp.2013.10.020","volume":"51","author":"E German\u00f2","year":"2014","unstructured":"German\u00f2 E, Italiano D, Lamberti M, Guerriero L, Privitera C, D\u2019Amico G, Siracusano R, Ingrassia M, Spina E, Calabr\u00f2 MP, Gagliano A (2014) ECG parameters in children and adolescents treated with aripiprazole and risperidone. Prog Neuropsychopharmacol Biol Psychiatry 51:23\u201327. https:\/\/doi.org\/10.1016\/j.pnpbp.2013.10.020","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"5885_CR15","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00213-017-4784-5","volume":"235","author":"KG Jensen","year":"2018","unstructured":"Jensen KG, G\u00e4rtner S, Correll CU, Rud\u00e5 D, Klauber DG, Stentebjerg-Olesen M, Fagerlund B, Jepsen JR, Fink-Jensen A, Juul K, Pagsberg AK (2018) Change and dispersion of QT interval during treatment with quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: results from the TEA trial. Psychopharmacology 235(3):681\u2013693. https:\/\/doi.org\/10.1007\/s00213-017-4784-5","journal-title":"Psychopharmacology"},{"issue":"4","key":"5885_CR16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1089\/cap.2011.0129","volume":"22","author":"JG Ho","year":"2012","unstructured":"Ho JG, Caldwell RL, McDougle CJ, Orsagh-Yentis DK, Erickson CA, Posey DJ, Stigler KA (2012) The effects of aripiprazole on electrocardiography in children with pervasive developmental disorders. J Child Adolesc Psychopharmacol 22(4):277\u2013283. https:\/\/doi.org\/10.1089\/cap.2011.0129","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"6","key":"5885_CR17","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1007\/s10072-011-0678-1","volume":"32","author":"M Gulisano","year":"2011","unstructured":"Gulisano M, Cal\u00ec PV, Cavanna AE, Eddy C, Rickards H, Rizzo R (2011) Cardiovascular safety of aripiprazole and pimozide in young patients with Tourette syndrome. Neurol Sci\u202f: Off J Ital Neurol Soc Ital Soc Clin Neurophysiol 32(6):1213\u20131217. https:\/\/doi.org\/10.1007\/s10072-011-0678-1","journal-title":"Neurol Sci : Off J Ital Neurol Soc Ital Soc Clin Neurophysiol"},{"issue":"1","key":"5885_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.5863\/1551-6776-26.1.87","volume":"26","author":"LM Hutchins","year":"2021","unstructured":"Hutchins LM, Shipman A, Zimmerman KO, Heath TS (2021) Evaluation of QTc interval effects of antipsychotic medications for intensive care unit delirium in pediatric patients. J Pediatr Pharmacol Ther\u202f: JPPT\u202f: Off J PPAG 26(1):87\u201391. https:\/\/doi.org\/10.5863\/1551-6776-26.1.87","journal-title":"J Pediatr Pharmacol Ther : JPPT : Off J PPAG"},{"issue":"3","key":"5885_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.5863\/1551-6776-26.3.271","volume":"26","author":"KM Hughes","year":"2021","unstructured":"Hughes KM, Thorndyke A, Tillman EM (2021) Incidence of corrected QT prolongation with concomitant methadone and atypical antipsychotics in critically ill children. J Pediatr Pharmacol Ther\u202f: JPPT\u202f: Off J PPAG 26(3):271\u2013276. https:\/\/doi.org\/10.5863\/1551-6776-26.3.271","journal-title":"J Pediatr Pharmacol Ther : JPPT : Off J PPAG"},{"issue":"1","key":"5885_CR20","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1089\/104454603321666216","volume":"13","author":"B McConville","year":"2003","unstructured":"McConville B, Carrero L, Sweitzer D, Potter L, Chaney R, Foster K, Sorter M, Friedman L, Browne K (2003) Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: an open-label extension trial. J Child Adolesc Psychopharmacol 13(1):75\u201382. https:\/\/doi.org\/10.1089\/104454603321666216","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"4","key":"5885_CR21","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.jelectrocard.2017.02.012","volume":"50","author":"D Karpuz","year":"2017","unstructured":"Karpuz D, Hallioglu O, Toros F, Tasdelen B (2017) The effect of metilpheniydate, risperidone and combination therapy on ECG in children with attention-deficit hyperactivity disorder. J Electrocardiol 50(4):410\u2013415. https:\/\/doi.org\/10.1016\/j.jelectrocard.2017.02.012","journal-title":"J Electrocardiol"},{"issue":"10","key":"5885_CR22","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1089\/cap.2016.0090","volume":"26","author":"LC Vo","year":"2016","unstructured":"Vo LC, Snyder C, McCracken C, McDougle CJ, McCracken JT, Aman MG, Tierney E, Arnold LE, Levi D, Kelleman M, Carroll D, Morrissey J, Vitiello B, Scahill L (2016) No apparent cardiac conduction effects of acute treatment with risperidone in children with autism spectrum disorder. J Child Adolesc Psychopharmacol 26(10):900\u2013908. https:\/\/doi.org\/10.1089\/cap.2016.0090","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"8","key":"5885_CR23","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1089\/cap.2012.0029","volume":"23","author":"RL Findling","year":"2013","unstructured":"Findling RL, Cavu\u015f I, Pappadopulos E, Vanderburg DG, Schwartz JH, Gundapaneni BK, DelBello MP (2013) Efficacy, long-term safety, and tolerability of ziprasidone in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol 23(8):545\u2013557. https:\/\/doi.org\/10.1089\/cap.2012.0029","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"7","key":"5885_CR24","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/s0002-9149(98)00006-x","volume":"81","author":"CM Pratt","year":"1998","unstructured":"Pratt CM, Camm AJ, Cooper W, Friedman PL, MacNeil DJ, Moulton KM, Pitt B, Schwartz PJ, Veltri EP, Waldo AL (1998) Mortality in the Survival With ORal D-sotalol (SWORD) trial: why did patients die? Am J Cardiol 81(7):869\u2013876. https:\/\/doi.org\/10.1016\/s0002-9149(98)00006-x","journal-title":"Am J Cardiol"},{"issue":"2","key":"5885_CR25","first-page":"154","volume":"25","author":"R Welch","year":"2000","unstructured":"Welch R, Chue P (2000) Antipsychotic agents and QT changes. J Psychiatry Neurosci: JPN 25(2):154\u2013160","journal-title":"J Psychiatry Neurosci: JPN"},{"issue":"2","key":"5885_CR26","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/S0022-3565(24)37654-2","volume":"286","author":"D Rampe","year":"1998","unstructured":"Rampe D, Murawsky MK, Grau J, Lewis EW (1998) The antipsychotic agent sertindole is a high affinity antagonist of the human cardiac potassium channel HERG. J Pharmacol Exp Ther 286(2):788\u2013793","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"5885_CR27","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/sj.bjp.0700989","volume":"120","author":"H Suessbrich","year":"1997","unstructured":"Suessbrich H, Sch\u00f6nherr R, Heinemann SH, Attali B, Lang F, Busch AE (1997) The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes. Br J Pharmacol 120(5):968\u2013974. https:\/\/doi.org\/10.1038\/sj.bjp.0700989","journal-title":"Br J Pharmacol"},{"issue":"6","key":"5885_CR28","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/00004714-199812000-00011","volume":"18","author":"MD Drici","year":"1998","unstructured":"Drici MD, Wang WX, Liu XK, Woosley RL, Flockhart DA (1998) Prolongation of QT interval in isolated feline hearts by antipsychotic drugs. J Clin Psychopharmacol 18(6):477\u2013481. https:\/\/doi.org\/10.1097\/00004714-199812000-00011","journal-title":"J Clin Psychopharmacol"},{"issue":"21","key":"5885_CR29","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1001\/jama.270.21.2590","volume":"270","author":"RR Makkar","year":"1993","unstructured":"Makkar RR, Fromm BS, Steinman RT, Meissner MD, Lehmann MH (1993) Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA 270(21):2590\u20132597. https:\/\/doi.org\/10.1001\/jama.270.21.2590","journal-title":"JAMA"},{"issue":"6","key":"5885_CR30","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1161\/01.cir.94.6.1471","volume":"94","author":"MD Drici","year":"1996","unstructured":"Drici MD, Burklow TR, Haridasse V, Glazer RI, Woosley RL (1996) Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart. Circulation 94(6):1471\u20131474. https:\/\/doi.org\/10.1161\/01.cir.94.6.1471","journal-title":"Circulation"},{"issue":"10","key":"5885_CR31","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1161\/01.cir.94.10.2535","volume":"94","author":"MH Lehmann","year":"1996","unstructured":"Lehmann MH, Hardy S, Archibald D, Quart B, MacNeil DJ (1996) Sex difference in risk of torsade de pointes with d, l-sotalol. Circulation 94(10):2535\u20132541. https:\/\/doi.org\/10.1161\/01.cir.94.10.2535","journal-title":"Circulation"},{"issue":"4","key":"5885_CR32","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1089\/cap.2011.0024","volume":"21","author":"CU Correll","year":"2011","unstructured":"Correll CU, Harris J, Figen V, Kane JM, Manu P (2011) Antipsychotic drug administration does not correlate with prolonged rate-corrected QT interval in children and adolescents: results from a nested case-control study. J Child Adolesc Psychopharmacol 21(4):365\u2013368. https:\/\/doi.org\/10.1089\/cap.2011.0024","journal-title":"J Child Adolesc Psychopharmacol"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-024-05885-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-024-05885-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-024-05885-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T22:47:00Z","timestamp":1737672420000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-024-05885-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,16]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["5885"],"URL":"https:\/\/doi.org\/10.1007\/s00431-024-05885-w","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,16]]},"assertion":[{"value":"26 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"20"}}